Canadian Drug Company Reports Positive Result On HIV Drug For Fat Disorder
Posted on June 19, 2008
Filed Under 365Gay, News
(Montreal, Quebec) Theratechnologies Inc. has reported positive results in a confirmatory Phase 3 clinical trial of its lead compound, tesamorelin, in patients with HIV-associated lipodystrophy.
Hong Kong reports 89 new HIV infection cases in Q1
Notorious gay basher kills himself in jail
Nepalese AIDS patients evicted
Tax company under fire for gay discrimination